Laurie D. Snyder, MD
Co-Associate Medical Director, Lung Transplant Program
Department / Division
Medicine /
Medicine-Pulmonary
Address
DUMC 103002
Durham, NC 27710
Appointment Telephone
919-684-2240
Office Telephone
919-684-2240
Fax Telephone
919-681-9571
- MD, Duke University School of Medicine, 2000
- Internal Medicine, University of California–San Francisco Medical Center, 2000-2003
- Pulmonary and Critical Care Medicine, Lung Transplant, Duke University Medical Center, 2003-2006
Clinical Interests
Lung transplant, immune mechanisms of transplant rejection, general pulmonary medicine
Research Interests
Lung transplantation, innate immunity, general pulmonary
This faculty member has no reported relationships with industry.
Representative Publications
Davis, WA; Finlen Copeland, CA; Todd, JL; Snyder, LD; Martissa, JA; Palmer, SM. Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation. American Journal of Transplantation. 2012;12:745-752.
(2012)
Abstract
Patel, N; Snyder, LD; Finlen-Copeland, A; Palmer, SM. Is prevention the best treatment? CMV after lung transplantation. American Journal of Transplantation. 2012;12:539-544.
(2012)
Abstract
Finlen Copeland, CA; Davis, WA; Snyder, LD; Banks, M; Avery, R; Davis, RD; Palmer, SM. Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial. Journal of Heart and Lung Transplantation. 2011;30:990-996.
(2011)
Abstract
Snyder, LD; Medinas, R; Chan, C; Sparks, S; Davis, WA; Palmer, SM; Weinhold, KJ. Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis. American Journal of Transplantation. 2011;11:553-560.
(2011)
Abstract
Finlen Copeland, CA; Snyder, LD; Zaas, DW; Turbyfill, WJ; Davis, WA; Palmer, SM. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. American Journal of Respiratory and Critical Care Medicine. 2010;182:784-789.
(2010)
Abstract
Snyder, LD; Finlen-Copeland, CA; Turbyfill, WJ; Howell, D; Willner, DA; Palmer, SM. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. American Journal of Respiratory and Critical Care Medicine. 2010;181:1391-1396.
(2010)
Abstract
Hartwig, MG; Snyder, LD; Appel, JZ; Cantu, E; Lin, SS; Palmer, SM; Davis, RD. Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation. Journal of Heart and Lung Transplantation. 2008;27:547-553.
(2008)
Abstract
Palmer, SM; Klimecki, W; Yu, L; Reinsmoen, NL; Snyder, LD; Ganous, TM; Burch, L; Schwartz, DA. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. American Journal of Transplantation. 2007;7:693-699.
(2007)
Abstract
Snyder, LD; Hartwig, MG; Ganous, T; Davis, RD; Herczyk, WF; Reinsmoen, NL; Schwartz, DA; Palmer, SM. Cytokine gene polymorphisms are not associated with bronchiolitis obliterans syndrome or survival after lung transplant. Journal of Heart and Lung Transplantation. 2006;25:1330-1335.
(2006)
Abstract
Snyder, LD; Palmer, SM. Immune mechanisms of lung allograft rejection. Seminars in Respiratory and Critical Care Medicine: pulmonology, critical care, allergy and immunology, infections. 2006;27:534-543.
(2006)
Abstract
